India to Italy: Pioglitazone Export Trade Route
India has recorded 56 verified shipments of Pioglitazone exported to Italy, representing a combined trade value of $1.2M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $21.5K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 78% of total export value with 42 shipments worth $943.5K USD. On the buying side, S C F SRL is the largest importer in Italy with $354.5K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Italy Pioglitazone corridor is one of India's established pharmaceutical export routes, with 56 shipments documented worth a combined $1.2M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's pioglitazone manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $21.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with pioglitazone's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 32.9%, placing it at rank #15 among India's top pioglitazone export destinations globally.
On the import side, key buyers of Indian pioglitazone in Italy include S C F SRL, TO THE ORDER, S.C.F. SRL and 8 others. S C F SRL is the single largest importer with 9 shipments valued at $354.5K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#15
- Annual growth+32.9%
- Demand growth+27.4%
- Regulatory ease80/100
Top 10 Indian Pioglitazone Exporters to Italy
Showing top 10 of 3 Indian suppliers exporting Pioglitazone to Italy, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $22.5K per shipment | 42 | $943.5K | 78.5% |
| 2 | INTAS PHARMACEUTICALS LTD Avg $21.2K per shipment | 7 | $148.6K | 12.4% |
| 3 | INTAS PHARMACEUTICALS LIMITED Avg $15.8K per shipment | 7 | $110.3K | 9.2% |
This table shows the top 10 of 3 Indian companies exporting pioglitazone to Italy, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED . INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 42 shipments worth $943.5K USD, giving it a 78% market share.
Top 10 Pioglitazone Importers in Italy
Showing top 10 of 11 known buyers in Italy receiving Pioglitazone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pioglitazone in Italy include S C F SRL, TO THE ORDER, S.C.F. SRL, ACCORD HEALTHCARE ITALIA SRL, S.C.F. SRL , among 11 total buyers. The largest importer is S C F SRL, accounting for $354.5K USD across 9 shipments — representing 29% of all pioglitazone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | S C F SRL | 9 | $354.5K | 29.5% |
| 2 | TO THE ORDER | 14 | $353.4K | 29.4% |
| 3 | S.C.F. SRL | 8 | $164.8K | 13.7% |
| 4 | ACCORD HEALTHCARE ITALIA SRL | 13 | $121.2K | 10.1% |
| 5 | S.C.F. SRL | 3 | $104.7K | 8.7% |
| 6 | DOC GENERICI SRL | 1 | $87.3K | 7.3% |
| 7 | Accord Healthcare Italia Srl | 3 | $10.2K | 0.8% |
| 8 | ACCORD HEALTHCARE ITALIA SRL. | 2 | $3.2K | 0.3% |
| 9 | ACCORD HEALTHCARE ITALIA SRL | 1 | $1.8K | 0.2% |
| 10 | PHARMA LOGISTIK AUSTRIA GMBH | 1 | $805 | 0.1% |
Showing top 10 of 11 Pioglitazone importers in Italy on this route.
Top 10 Pioglitazone Formulations Imported by Italy
Showing top 10 of 29 product formulations shipped on the India to Italy Pioglitazone route, ranked by trade value
Italy imports a wide range of pioglitazone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICAL DRUGS & MEDICINE.PIOGLITAZONE 30MG 2X14T (DOC ITALY EACH UNCOATEDTABLET CONTS.PIOGLITAZONE HYDROCHLORIDE — accounts for $192.4K USD across 5 shipments. There are 29 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL DRUGS & MEDICINE.PIOGLITAZONE 30MG 2X14T (DOC ITALY EACH UNCOATEDTABLET CONTS.PIOGLITAZONE HYDROCHLORIDE | 5 | $192.4K | 16.0% |
| 2 | PH.DRU.& MED.: PIOGLITAZONE 30MG TABLETS | 3 | $115.1K | 9.6% |
| 3 | PHARM.DRUGS&MEDI.PIOGLITAZONE 15MG 2X14T | 3 | $104.7K | 8.7% |
| 4 | PH.DRU.& MED.: PIOGLITAZONE 15MG TABLETS | 2 | $100.9K | 8.4% |
| 5 | PIOGLITAZONE ACCORD 45 MG(PIOGLITAZONE HYDROCHLORIDE EQ.TO PIOGLITAZONE 45MG)B#D2302628 MFG.09/23,EXP.8/27(5641X2X14TAB) | 1 | $98.3K | 8.2% |
| 6 | PH.DRU.& MED.PIOGLITAZONE 15MG 2X14T(DOC ITALY EACH UNC. TAB CONTA. PIOGLITAZONE HYDROCHLORIDE EQ. TO PIOGLITAZONE 15 MG | 3 | $89.9K | 7.5% |
| 7 | PHARMA.DRUGS & MEDICINE.PIOGLITAZONE 15MG 2X14T (DOC ITALY EACH UNCOATED TABLETCONTS. PIOGLITAZONE HYDROCHLORIDE EQ. TO | 2 | $89.3K | 7.4% |
| 8 | PH.DRU.& MED.: PIOGLITAZONE 15MG TABLETSEACH TABLET CONTAINS: PIOGLITAZONE HCLEQ. TO. PIOGLITAZONE 15MG [2X14T PER P | 1 | $87.3K | 7.3% |
| 9 | PH.DRU.& MED.: PIOGLITAZONE 30MG TABLETS(EACH TABLET CONTAINS: PIOGLITAZONE HCLEQ. TO. PIOGLITAZONE 30MG) [2X14T PER P | 4 | $74.6K | 6.2% |
| 10 | PIOGLITAZONE 30MG 2X14TPIOGLITAZONE HYD | 2 | $74.1K | 6.2% |
Showing top 10 of 29 Pioglitazone formulations imported by Italy on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 17 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's pioglitazone exports to Italy are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 42 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Italy benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $21.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ph.dru.& med.: pioglitazone 30mg tablets and pharm.drugs&medi.pioglitazone 15mg 2x14t , suggesting that buyers in Italy tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, S C F SRL is the largest importer with 9 shipments worth $354.5K USD — representing 29% of all pioglitazone imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.2M
- Avg. Shipment
- $21.5K
- Suppliers
- 3
- Buyers
- 11
- Transit (Sea)
- ~20 days
- Annual Growth
- +32.9%
Related Analysis
Other Pioglitazone Routes
Unlock the Full India to Italy Pioglitazone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 56 shipments on this route.
Frequently Asked Questions — India to Italy Pioglitazone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pioglitazone to Italy?
The leading Indian exporters of Pioglitazone to Italy are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED . INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 78% of total trade value on this route.
Q What is the total value of Pioglitazone exports from India to Italy?
India exports Pioglitazone to Italy worth approximately $1.2M USD across 56 recorded shipments. The average value per shipment is $21.5K USD.
Q Which ports does India use to ship Pioglitazone to Italy?
The most active port of origin is DELHI AIR with 17 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Italy for Pioglitazone?
The average transit time for Pioglitazone shipments from India to Italy is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Italy Pioglitazone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.9% with demand growth tracking at 27.4%. The route is ranked #15 among India's top Pioglitazone export destinations globally.
Q How many suppliers are active on the India to Italy Pioglitazone route?
There are currently 3 active Indian suppliers exporting Pioglitazone to Italy. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 78% of total shipment value.
Q Who are the main importers of Pioglitazone from India in Italy?
The leading importers of Indian Pioglitazone in Italy include S C F SRL, TO THE ORDER, S.C.F. SRL, ACCORD HEALTHCARE ITALIA SRL, S.C.F. SRL . S C F SRL is the largest buyer with 9 shipments worth $354.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Italy export trade corridor identified from Indian Customs (DGFT) records for Pioglitazone.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 11 importers in Italy matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 56 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
56 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists